REFERENCES
Aman, M. G. (1982). Stimulant drug effects in developmental disorders and hyperactivity-Toward a resolution of disparate findings. Journal of Autism and Developmental Disorders, 12, 385–398.
Aman, M. (1996). Stimulant drugs in the developmental disabilities revisited. Journal of Developmental and Physical Disabilities, 8, 347–365.
Campbell, M., & Palij, M. (1985). Behavioral and cognitive measures used in psychopharmacological studies of infantile autism. Psychopharmacology Bulletin, 21, 1047–1053.
Campbell, M., Rapoport, J. L., & Simpson, G. M. (1999). Antipsychotics in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 537–545.
Gittelman-Klein, R., Klein, D. F., Katz, S., Saraf, K., & Pollack, E. (1976). Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results. Archives of General Psychiatry, 33, 1217–1231.
Levy, F., & Hobbes, G. (1996). Does haloperidol block methylphenidate? Motivation or attention? Psychopharmacology, 126, 70–74.
Lovaas, O. I., Koegel, R. L., & Schreibman, L. (1979). Stimulus over-selectivity in autism: A review of research. Psychological Bulletin, 86, 1236–1254.
Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Freed, J., Bridge, J., & Greenhill, L. (1995). Use of methylphenidate in the treatment of children with autistic disorder. Journal of Autism and Developmental Disorders, 25, 283–294.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nicolson, R., Castellanos, F.X. Commentary: Considerations on the Pharmacotherapy of Attention Deficits and Hyperactivity in Children with Autism and Other Pervasive Developmental Disorders. J Autism Dev Disord 30, 461–462 (2000). https://doi.org/10.1023/A:1005511809545
Issue Date:
DOI: https://doi.org/10.1023/A:1005511809545